1. Medtech Insight
  2. >>Business

Wright To Pay $435M For Cartiva To Add Synthetic Cartilage Implant

 
• By Reed Miller

Cartiva's Synthetic Cartilage Implant for treating arthritis at the base of the great toe will instantly be Wright's most profitable product and one of its fastest growing.

Knee joint

Wright Medical Group NV will acquire Cartiva Inc. to accelerate growth of its extremities business with Cartiva's Synthetic Cartilage Implant (SCI) for treating arthritis at the base of the great toe.

Under the deal announced Aug. 27, Wright will acquire 100% of Cartiva’s outstanding equity on a fully diluted basis for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

Execs On The Move: 26-30 May 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Where Do Questions Surrounding The EU’s AI Act Leave The Medtech Industry?

 
• By Amanda Maxwell

The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.

HistoSonics’ Edison System Gains Limited UK Access, While Awaiting CE Marking

 
• By Shubham Singh

While HistoSonics is awaiting the CE mark in Europe, it hit a major milestone by securing early limited market access in Great Britain under a Unmet Clinical Need Authorization (UCNA), bringing its noninvasive histotripsy treatment to patients with liver tumors.